3'- angeloyloxy- 4'- acetoxy- 3',4'- dihydroseselin

Subscribe to Selected New Research on 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin

6 relevant articles (0 outcomes, 2 trials/studies) found for this Bio-Agent

Description: a pyranocoumarin compound; isolated from a Chinese medicinal plant Bai-Hua Qian-Hu; structure given in first source; RN given refers to compound with no isomeric designation

Also Known As:

(9alpha(Z),10alpha)-(+-) of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin; 9R-(9alpha(Z),10alpha) of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin; 9S-(9alpha(Z),10alpha) of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin; 9alpha(E),10alpha of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin; 9alpha(E),10beta of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin; Pd-Ia

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

Pyrans: 3

Benzopyrans: 5

Coumarins: 132

3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin: 6

2-Ring Heterocyclic Compounds

Benzopyrans: 5

Coumarins: 132

3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin: 6

Related Diseases

1.	Ischemia 09/01/1994 - "Effects of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin on myocardial dysfunction after a brief ischemia in anesthetized dogs." 06/02/1994 - "We examined the effect of Pd-Ia on cardiohemodynamics and regional myocardial dysfunction after transient ischemia in anesthetized open-chest dogs" 09/01/2002 - "AIM: To investigate the effects of dl-praeruptorin (Pd-Ia) on interleukin-6 (IL-6) level and apoptosis-related protein expression in ischemia-reperfusion myocardium" 12/20/2007 - "The purpose of this study was, for the first time, to evaluate the in vivo effects of Pd-Ia on IF desmin and vimentin content in order to further explore its cardioprotection against ischemia and elucidate its mechanism of action" 12/20/2007 - "CONCLUSION: Pd-Ia protectively increased IF desmin and vimentin content in ischemia/reperfusion myocardiocytes, which might be partially responsible for its cardioprotection against ischemia." Get all the results and reference details, order at left...
2.	Coronary Occlusion 06/02/1994 - "Infusion of Pd-Ia was started 15 min before coronary occlusion" Get all the results and reference details, order at left...
3.	Myocardial Stunning (Stunned Myocardium) 09/01/1994 - "These findings revealed that Pd-Ia had a cardioprotective action in stunned myocardium." Get all the results and reference details, order at left...
4.	Hypotension (Low Blood Pressure) 09/01/2002 - "RESULTS: Pd-Ia 2.0 mg/kg iv lowered serum IL-6 level and Fas, bax, bcl-2 expression under conditions with hypotension and without changes on heart rate, but increased the ratio of bcl-2/bax" Get all the results and reference details, order at left...
5.	Hepatitis 01/01/2001 - "The effects of coumarin derivatives, osthole, imperatorin, Pd-Ia, Pd-II and Pd-III, on mice concanavalin A (Con A) (0.2 mg/mouse, i.v.)-induced hepatitis were studied" Get all the results and reference details, order at left...
5 Diseases and 6 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	praeruptorin A
2.	NF-kappa B (NF-kB)
3.	Vimentin
4.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
5.	Desmin
6.	Interleukin-6 (Interleukin 6)
7.	Proteins (Proteins, Gene)
8.	Concanavalin A
9.	osthol
10.	imperatorin
11 Drugs and Important Bio-Agents and 4 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>